News

Filter

Current filters:

Diabetes

1 to 9 of 745 results

‘New option’ for diabetes as Sanofi receives FDA approval of Toujeo

‘New option’ for diabetes as Sanofi receives FDA approval of Toujeo

26-02-2015

The US Food and Drug Administration has approved French pharma major Sanofi’s Toujeo (insulin glargine…

DiabetesPharmaceuticalRegulationSanofiToujeoUSA

Eli Lilly delays US and Europe filings for new diabetes agent peglispro

23-02-2015

US pharma major Eli Lilly says it is delaying the submission of its basal insulin peglispro (BIL) to…

DiabetesEli LillyEuropepeglisproPharmaceuticalRegulationUSA

Novo Nordisk shares jump on positive trial results with OG217SC

Novo Nordisk shares jump on positive trial results with OG217SC

20-02-2015

Shares of Danish diabetes care giant Novo Nordisk jumped 5% to 312.20 Danish kroner in early afternoon…

DenmarkDiabetesNovo NordiskOG217SCPharmaceuticalResearchsemaglutide

New Zealand’s PHARMAC calls for information on anti-diabetic agents

New Zealand’s PHARMAC calls for information on anti-diabetic agents

12-02-2015

New Zealand’s Pharmaceutical Management Agency, PHARMAC, today revealed it is interested in receiving…

DiabetesFinancialHealthcareNew ZealandPharmaceutical

Novo Nordisk and Karolinska Institutet collaborate on diabetes postdoctoral research program

Novo Nordisk and Karolinska Institutet collaborate on diabetes postdoctoral research program

10-02-2015

Danish insulin giant Novo Nordisk is to join forces with Swedish researchers Karolinska Institutet for…

DenmarkDiabetesNovo NordiskPharmaceuticalResearchSweden

IQWiG sees benefits for Triumeq and Eperzan

05-02-2015

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) has announced its latest findings…

Anti-viralsDiabetesEperzanGermanyGlaxoSmithKlinePharmaceuticalPricingRegulationTriumeqViiV Healthcare

Isis Pharma stock falls after data from Phase II study of ISIS-PTP1B Rx

Isis Pharma stock falls after data from Phase II study of ISIS-PTP1B Rx

04-02-2015

US drugmaker Isis Pharmaceuticals has announced top-line results from a Phase II study of ISIS-PTP1BRx…

DiabetesIsis PharmaceuticalsPharmaceuticalResearchUSA

Sanofi and MannKind's Afrezza now available in the USA

Sanofi and MannKind's Afrezza now available in the USA

03-02-2015

The only inhaled insulin Afrezza (human insulin) Inhalation Powder, developed by French drug major Sanofi…

AfrezzaDiabetesMannKindMarkets & MarketingPharmaceuticalSanofiUSA

1 to 9 of 745 results

COMPANY SPOTLIGHT

Menarini

Back to top